During the American Seed Trade Association CSS & Seed Expo in Chicago this week, Arcadia Biosciences announced the launch of a new product line – GoodHemp. As the company’s new brand for delivering genetically superior hemp seeds, transplants, flower and extracts, GoodHemp’s first commercial product is a disease resistant and ultra-low THC hemp seed.
Accepting advance orders now, the first variety in GoodHemp’s catalog – Complia Bot+ – is a widely adapted cannabis strain that delivers high CBD content (more than 10 percent) with ultra-low tetrahydrocannabinol (THC), the psychoactive compound in cannabis. It is part of the Complia hemp seed line Arcadia is bringing to market through GoodHemp, with four additional proprietary varieties in early adopter farmer trials with sales expected in the 2020 season.
This innovation comes just months after the USDA’s Interim Final Ruling for hemp cultivation, which mandates that states test hemp crops and dispose of “hot” crops that exceed 0.3 percent THC. While hemp farmers will have access to crop protection options, the destruction of hot crops that fail these stringent inspections will not be a covered loss under crop insurance programs. In 2019 alone, approximately 20 percent of U.S. hemp crops were non-compliant, representing $2 billion in losses for growers.
Arcadia Biosciences CEO Matt Plavan talks about the new brand in this interview:
GoodHemp interview with Arcadia Biosciences CEO Matt Plavan